Skip to content
lifestyle.realie.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cocrystal Pharma, Inc.
Cocrystal Pharma Provides Business Update and Reports Third Quarter 2026 Financial Results
November 15, 2026
Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment
September 9, 2026
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
August 17, 2026
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
August 3, 2026
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
June 3, 2026
Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza
May 26, 2026